

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.90355478 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.74705042 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.06228984 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.03967562 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.89053025 |
| 6 | glutamate secretion (GO:0014047) | 5.88326606 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.84171162 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.81342879 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.62421193 |
| 10 | vocalization behavior (GO:0071625) | 5.45339177 |
| 11 | neuronal action potential propagation (GO:0019227) | 5.32314463 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.17248481 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 5.01321758 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.75649429 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.75606428 |
| 16 | protein localization to synapse (GO:0035418) | 4.70367343 |
| 17 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.65125916 |
| 18 | central nervous system myelination (GO:0022010) | 4.59810511 |
| 19 | axon ensheathment in central nervous system (GO:0032291) | 4.59810511 |
| 20 | cerebellar granule cell differentiation (GO:0021707) | 4.49533431 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.49412400 |
| 22 | amino acid import (GO:0043090) | 4.48447022 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 4.41659605 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.40125006 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.36709592 |
| 26 | exploration behavior (GO:0035640) | 4.34725246 |
| 27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.27266377 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 4.26083168 |
| 29 | proline transport (GO:0015824) | 4.10920250 |
| 30 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.01745385 |
| 31 | sodium ion export (GO:0071436) | 3.99341386 |
| 32 | glutamate receptor signaling pathway (GO:0007215) | 3.98775128 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.98758845 |
| 34 | long-term memory (GO:0007616) | 3.97746691 |
| 35 | regulation of synapse structural plasticity (GO:0051823) | 3.96663861 |
| 36 | postsynaptic membrane organization (GO:0001941) | 3.95449103 |
| 37 | regulation of synapse maturation (GO:0090128) | 3.94514918 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.90360275 |
| 39 | neuromuscular process controlling posture (GO:0050884) | 3.90156922 |
| 40 | positive regulation of membrane potential (GO:0045838) | 3.89475544 |
| 41 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.86626241 |
| 42 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.85992502 |
| 43 | gamma-aminobutyric acid transport (GO:0015812) | 3.85947124 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.84532216 |
| 45 | glycine transport (GO:0015816) | 3.83870863 |
| 46 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.81806314 |
| 47 | regulation of neurotransmitter secretion (GO:0046928) | 3.81597060 |
| 48 | activation of protein kinase A activity (GO:0034199) | 3.80936377 |
| 49 | neurotransmitter transport (GO:0006836) | 3.76451699 |
| 50 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.75679148 |
| 51 | neuromuscular process controlling balance (GO:0050885) | 3.74292160 |
| 52 | regulation of dendritic spine development (GO:0060998) | 3.73062596 |
| 53 | regulation of synaptic plasticity (GO:0048167) | 3.70755027 |
| 54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.69814035 |
| 55 | neuron cell-cell adhesion (GO:0007158) | 3.65764777 |
| 56 | positive regulation of synapse maturation (GO:0090129) | 3.63261396 |
| 57 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.62085341 |
| 58 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.60048870 |
| 59 | cell communication by electrical coupling (GO:0010644) | 3.59511378 |
| 60 | response to pheromone (GO:0019236) | 3.58610616 |
| 61 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.53869617 |
| 62 | membrane depolarization during action potential (GO:0086010) | 3.52636931 |
| 63 | regulation of neurotransmitter transport (GO:0051588) | 3.50038996 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 3.45292587 |
| 65 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.44842448 |
| 66 | acidic amino acid transport (GO:0015800) | 3.44142461 |
| 67 | cellular sodium ion homeostasis (GO:0006883) | 3.43754529 |
| 68 | positive regulation of neurotransmitter transport (GO:0051590) | 3.39986081 |
| 69 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.38685274 |
| 70 | neurotransmitter uptake (GO:0001504) | 3.38422210 |
| 71 | L-amino acid import (GO:0043092) | 3.38298592 |
| 72 | transmission of nerve impulse (GO:0019226) | 3.36398356 |
| 73 | establishment of synaptic vesicle localization (GO:0097480) | 3.32704886 |
| 74 | synaptic vesicle transport (GO:0048489) | 3.32704886 |
| 75 | regulation of vesicle fusion (GO:0031338) | 3.32302386 |
| 76 | long-term synaptic potentiation (GO:0060291) | 3.31732284 |
| 77 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.30861470 |
| 78 | vesicle docking involved in exocytosis (GO:0006904) | 3.29351020 |
| 79 | membrane depolarization (GO:0051899) | 3.27546054 |
| 80 | membrane hyperpolarization (GO:0060081) | 3.26760741 |
| 81 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.22346788 |
| 82 | regulation of exocytosis (GO:0017157) | 3.20926781 |
| 83 | innervation (GO:0060384) | 3.20469727 |
| 84 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.19419166 |
| 85 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.19292672 |
| 86 | dendritic spine organization (GO:0097061) | 3.19103060 |
| 87 | neuromuscular process (GO:0050905) | 3.18792973 |
| 88 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.17225648 |
| 89 | neuronal ion channel clustering (GO:0045161) | 3.16854664 |
| 90 | * regulation of voltage-gated calcium channel activity (GO:1901385) | 3.15582043 |
| 91 | response to auditory stimulus (GO:0010996) | 3.15250518 |
| 92 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.14925692 |
| 93 | acid secretion (GO:0046717) | 3.14162665 |
| 94 | phosphorelay signal transduction system (GO:0000160) | 3.13906799 |
| 95 | cell differentiation in hindbrain (GO:0021533) | 3.13760852 |
| 96 | regulation of ARF protein signal transduction (GO:0032012) | 3.13103512 |
| 97 | dicarboxylic acid transport (GO:0006835) | 3.12935209 |
| 98 | cell migration in hindbrain (GO:0021535) | 3.12479463 |
| 99 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.11949972 |
| 100 | potassium ion import (GO:0010107) | 3.11485399 |
| 101 | synaptic transmission (GO:0007268) | 3.08960938 |
| 102 | L-glutamate transport (GO:0015813) | 3.08334501 |
| 103 | regulation of synaptic transmission (GO:0050804) | 3.08079528 |
| 104 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.06966912 |
| 105 | positive regulation of dendrite development (GO:1900006) | 3.06580773 |
| 106 | signal release (GO:0023061) | 3.06177304 |
| 107 | auditory behavior (GO:0031223) | 3.05734401 |
| 108 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.04940731 |
| 109 | positive regulation of synaptic transmission (GO:0050806) | 3.02874915 |
| 110 | dendrite morphogenesis (GO:0048813) | 3.02654429 |
| 111 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.02403424 |
| 112 | long term synaptic depression (GO:0060292) | 3.01759577 |
| 113 | potassium ion homeostasis (GO:0055075) | 3.01048830 |
| 114 | vesicle transport along microtubule (GO:0047496) | 3.00997372 |
| 115 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.00538284 |
| 116 | chemosensory behavior (GO:0007635) | 3.00306286 |
| 117 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.96694591 |
| 118 | positive regulation of dendritic spine development (GO:0060999) | 2.96020685 |
| 119 | neuromuscular synaptic transmission (GO:0007274) | 2.95462681 |
| 120 | learning (GO:0007612) | 2.94961321 |
| 121 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.94529146 |
| 122 | adult walking behavior (GO:0007628) | 2.93779088 |
| 123 | prepulse inhibition (GO:0060134) | 2.92261872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.00314048 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.12669692 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06412170 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.04746185 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00863841 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.93445650 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.85016625 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.84387912 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.84387912 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.79767857 |
| 11 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.77123145 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.56153884 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56136395 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51679821 |
| 15 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.50648140 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48825100 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44016853 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41143802 |
| 19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.37225804 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.34500118 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.32770785 |
| 22 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.30244340 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.25601646 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19726679 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.04838973 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.99000019 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88629595 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.86851763 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70921491 |
| 30 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.62738967 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62082004 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59839649 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59101728 |
| 34 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.42863321 |
| 35 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.42679459 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42081185 |
| 37 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.39945062 |
| 38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37903763 |
| 39 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32588841 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30446034 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27346299 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27204766 |
| 43 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25056482 |
| 44 | AR_19668381_ChIP-Seq_PC3_Human | 1.24032615 |
| 45 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.21532632 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20358018 |
| 47 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20108265 |
| 48 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18793674 |
| 49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15687657 |
| 50 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15640523 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15079157 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14784381 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14170212 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14008663 |
| 55 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.13855180 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12036096 |
| 57 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11136351 |
| 58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11026477 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10990652 |
| 60 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.09782002 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09137001 |
| 62 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.08887563 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08414193 |
| 64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08407527 |
| 65 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.07361985 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05522422 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03480177 |
| 68 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.02490055 |
| 69 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.02305833 |
| 70 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02090756 |
| 71 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01900401 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01649233 |
| 73 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00832287 |
| 74 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99389071 |
| 75 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98915389 |
| 76 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98826995 |
| 77 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.98699830 |
| 78 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.97589089 |
| 79 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.95673946 |
| 80 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94993636 |
| 81 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94700389 |
| 82 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94681443 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94418104 |
| 84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93054970 |
| 85 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.93032383 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92915451 |
| 87 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92427604 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92403050 |
| 89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91980117 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91769664 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91370706 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90698970 |
| 93 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.90540457 |
| 94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89838844 |
| 95 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89120764 |
| 96 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88110527 |
| 97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88001505 |
| 98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86529342 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86314695 |
| 100 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.85857423 |
| 101 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85528364 |
| 102 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.85338699 |
| 103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.85025854 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85020163 |
| 105 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84392908 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83995243 |
| 107 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.83664574 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82517923 |
| 109 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82055579 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80835534 |
| 111 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.80744334 |
| 112 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.80540601 |
| 113 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80502907 |
| 114 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.80146872 |
| 115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80090147 |
| 116 | P68_20966046_ChIP-Seq_HELA_Human | 0.79783831 |
| 117 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79553025 |
| 118 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78492341 |
| 119 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77625090 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77557764 |
| 121 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.72729250 |
| 122 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.71314383 |
| 123 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.69932043 |
| 124 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.68693636 |
| 125 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.68665040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.98078006 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 4.22148390 |
| 3 | MP0003880_abnormal_central_pattern | 4.16841940 |
| 4 | MP0004270_analgesia | 3.88111746 |
| 5 | MP0009046_muscle_twitch | 3.41091327 |
| 6 | MP0009745_abnormal_behavioral_response | 3.37191589 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.29576183 |
| 8 | MP0002064_seizures | 3.17554909 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.10465468 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.89743393 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.84137224 |
| 12 | MP0002272_abnormal_nervous_system | 2.76824351 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.70996593 |
| 14 | MP0001486_abnormal_startle_reflex | 2.65755050 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.57679787 |
| 16 | MP0002822_catalepsy | 2.49510888 |
| 17 | MP0002736_abnormal_nociception_after | 2.46538952 |
| 18 | MP0004858_abnormal_nervous_system | 2.25829412 |
| 19 | MP0008569_lethality_at_weaning | 2.25477719 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.24933652 |
| 21 | MP0001970_abnormal_pain_threshold | 2.08481128 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.05965593 |
| 23 | MP0002067_abnormal_sensory_capabilities | 2.03008069 |
| 24 | MP0001440_abnormal_grooming_behavior | 2.01848606 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.88814031 |
| 26 | MP0004811_abnormal_neuron_physiology | 1.88158173 |
| 27 | MP0003879_abnormal_hair_cell | 1.86680691 |
| 28 | MP0002184_abnormal_innervation | 1.84700364 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.76988945 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.71439564 |
| 31 | MP0000955_abnormal_spinal_cord | 1.70561109 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.62689327 |
| 33 | MP0004924_abnormal_behavior | 1.62689327 |
| 34 | MP0003329_amyloid_beta_deposits | 1.62304803 |
| 35 | MP0000778_abnormal_nervous_system | 1.56549788 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.53627356 |
| 37 | MP0004885_abnormal_endolymph | 1.51333788 |
| 38 | MP0002882_abnormal_neuron_morphology | 1.47692958 |
| 39 | MP0003633_abnormal_nervous_system | 1.46037640 |
| 40 | MP0002066_abnormal_motor_capabilities/c | 1.43869054 |
| 41 | MP0001502_abnormal_circadian_rhythm | 1.36725569 |
| 42 | MP0003787_abnormal_imprinting | 1.35330964 |
| 43 | MP0004142_abnormal_muscle_tone | 1.32378512 |
| 44 | MP0001984_abnormal_olfaction | 1.31840366 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.30662741 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.28394576 |
| 47 | MP0003283_abnormal_digestive_organ | 1.26362880 |
| 48 | MP0003123_paternal_imprinting | 1.23220634 |
| 49 | MP0003631_nervous_system_phenotype | 1.22574850 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.16189728 |
| 51 | MP0005551_abnormal_eye_electrophysiolog | 1.12166146 |
| 52 | MP0008961_abnormal_basal_metabolism | 1.06108323 |
| 53 | MP0002229_neurodegeneration | 1.05625784 |
| 54 | MP0002152_abnormal_brain_morphology | 1.05542129 |
| 55 | MP0003075_altered_response_to | 1.01961366 |
| 56 | MP0000751_myopathy | 1.00582863 |
| 57 | MP0008872_abnormal_physiological_respon | 1.00435711 |
| 58 | MP0004147_increased_porphyrin_level | 0.98338089 |
| 59 | MP0001346_abnormal_lacrimal_gland | 0.94875570 |
| 60 | MP0001177_atelectasis | 0.94498309 |
| 61 | MP0003632_abnormal_nervous_system | 0.90534737 |
| 62 | MP0008874_decreased_physiological_sensi | 0.90296763 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 0.88481913 |
| 64 | MP0000569_abnormal_digit_pigmentation | 0.86950945 |
| 65 | MP0004742_abnormal_vestibular_system | 0.86548142 |
| 66 | MP0005394_taste/olfaction_phenotype | 0.84789500 |
| 67 | MP0005499_abnormal_olfactory_system | 0.84789500 |
| 68 | MP0010386_abnormal_urinary_bladder | 0.83500239 |
| 69 | MP0004233_abnormal_muscle_weight | 0.82043405 |
| 70 | MP0003634_abnormal_glial_cell | 0.81633348 |
| 71 | MP0003122_maternal_imprinting | 0.81623565 |
| 72 | MP0002090_abnormal_vision | 0.81597408 |
| 73 | MP0002752_abnormal_somatic_nervous | 0.81234919 |
| 74 | MP0001963_abnormal_hearing_physiology | 0.81203617 |
| 75 | MP0005623_abnormal_meninges_morphology | 0.80798696 |
| 76 | MP0002638_abnormal_pupillary_reflex | 0.80588591 |
| 77 | MP0008877_abnormal_DNA_methylation | 0.80578036 |
| 78 | MP0004085_abnormal_heartbeat | 0.79980815 |
| 79 | MP0001348_abnormal_lacrimal_gland | 0.79483338 |
| 80 | MP0001485_abnormal_pinna_reflex | 0.79102223 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 0.79083743 |
| 82 | MP0003690_abnormal_glial_cell | 0.77632825 |
| 83 | MP0001529_abnormal_vocalization | 0.75690885 |
| 84 | MP0004130_abnormal_muscle_cell | 0.74155704 |
| 85 | MP0001905_abnormal_dopamine_level | 0.73982480 |
| 86 | MP0002653_abnormal_ependyma_morphology | 0.70761745 |
| 87 | MP0004043_abnormal_pH_regulation | 0.69680030 |
| 88 | MP0001188_hyperpigmentation | 0.69674065 |
| 89 | MP0000920_abnormal_myelination | 0.68888706 |
| 90 | MP0005535_abnormal_body_temperature | 0.67345056 |
| 91 | MP0000013_abnormal_adipose_tissue | 0.65230043 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.62548220 |
| 93 | MP0004484_altered_response_of | 0.62112820 |
| 94 | MP0006072_abnormal_retinal_apoptosis | 0.61828574 |
| 95 | MP0003646_muscle_fatigue | 0.61513915 |
| 96 | MP0004215_abnormal_myocardial_fiber | 0.59587826 |
| 97 | MP0004510_myositis | 0.59431171 |
| 98 | MP0000631_abnormal_neuroendocrine_gland | 0.59174784 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.59028270 |
| 100 | MP0003045_fibrosis | 0.56529518 |
| 101 | MP0000604_amyloidosis | 0.56508988 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.56424604 |
| 103 | MP0005166_decreased_susceptibility_to | 0.55804474 |
| 104 | MP0010769_abnormal_survival | 0.55542832 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.55421993 |
| 106 | MP0005253_abnormal_eye_physiology | 0.54730327 |
| 107 | MP0000026_abnormal_inner_ear | 0.54564472 |
| 108 | MP0001943_abnormal_respiration | 0.54375981 |
| 109 | MP0003861_abnormal_nervous_system | 0.54279309 |
| 110 | MP0003956_abnormal_body_size | 0.48520021 |
| 111 | MP0010768_mortality/aging | 0.48254470 |
| 112 | MP0010770_preweaning_lethality | 0.46121811 |
| 113 | MP0002082_postnatal_lethality | 0.46121811 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.46099327 |
| 115 | MP0002089_abnormal_postnatal_growth/wei | 0.45810886 |
| 116 | MP0000579_abnormal_nail_morphology | 0.45060501 |
| 117 | MP0002873_normal_phenotype | 0.44429399 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.43870534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.77996434 |
| 2 | Focal motor seizures (HP:0011153) | 7.44528489 |
| 3 | Focal seizures (HP:0007359) | 5.73233259 |
| 4 | Visual hallucinations (HP:0002367) | 5.40788617 |
| 5 | Febrile seizures (HP:0002373) | 5.23671568 |
| 6 | Action tremor (HP:0002345) | 4.93329624 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.90796115 |
| 8 | Atonic seizures (HP:0010819) | 4.90082053 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.78452912 |
| 10 | Absence seizures (HP:0002121) | 4.02816932 |
| 11 | Neurofibrillary tangles (HP:0002185) | 3.88192684 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.87333933 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.79047102 |
| 14 | Cerebral hypomyelination (HP:0006808) | 3.73877872 |
| 15 | Dialeptic seizures (HP:0011146) | 3.66128523 |
| 16 | Ankle clonus (HP:0011448) | 3.47325540 |
| 17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.40400831 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 3.38497124 |
| 19 | Limb dystonia (HP:0002451) | 3.34954088 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 3.34563749 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.32505072 |
| 22 | Poor eye contact (HP:0000817) | 3.31845424 |
| 23 | Depression (HP:0000716) | 3.24881919 |
| 24 | Ventricular fibrillation (HP:0001663) | 3.18855703 |
| 25 | Annular pancreas (HP:0001734) | 3.16160063 |
| 26 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.15821027 |
| 27 | Broad-based gait (HP:0002136) | 3.14725119 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 3.11536794 |
| 29 | Dysmetria (HP:0001310) | 3.07592922 |
| 30 | Impaired smooth pursuit (HP:0007772) | 3.06700801 |
| 31 | Postural instability (HP:0002172) | 3.04800075 |
| 32 | Genetic anticipation (HP:0003743) | 3.02404425 |
| 33 | Impaired social interactions (HP:0000735) | 2.97796394 |
| 34 | Abnormal social behavior (HP:0012433) | 2.97796394 |
| 35 | Amblyopia (HP:0000646) | 2.90478885 |
| 36 | Truncal ataxia (HP:0002078) | 2.88111247 |
| 37 | Bundle branch block (HP:0011710) | 2.82466677 |
| 38 | Anxiety (HP:0000739) | 2.82235588 |
| 39 | Hemiplegia (HP:0002301) | 2.78603816 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.75134848 |
| 41 | Dysmetric saccades (HP:0000641) | 2.63503956 |
| 42 | Urinary urgency (HP:0000012) | 2.62017731 |
| 43 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.61885551 |
| 44 | Akinesia (HP:0002304) | 2.61641136 |
| 45 | Scanning speech (HP:0002168) | 2.59252060 |
| 46 | Intention tremor (HP:0002080) | 2.54691911 |
| 47 | Papilledema (HP:0001085) | 2.53911444 |
| 48 | Hemiparesis (HP:0001269) | 2.53675664 |
| 49 | Torticollis (HP:0000473) | 2.50658748 |
| 50 | Apathy (HP:0000741) | 2.49080908 |
| 51 | Peripheral hypomyelination (HP:0007182) | 2.46571808 |
| 52 | Spastic gait (HP:0002064) | 2.42681363 |
| 53 | Pointed chin (HP:0000307) | 2.42006919 |
| 54 | Stereotypic behavior (HP:0000733) | 2.41572643 |
| 55 | Status epilepticus (HP:0002133) | 2.41167401 |
| 56 | Bradykinesia (HP:0002067) | 2.39353836 |
| 57 | Spastic tetraparesis (HP:0001285) | 2.38474231 |
| 58 | Sleep apnea (HP:0010535) | 2.38345363 |
| 59 | Choreoathetosis (HP:0001266) | 2.37525039 |
| 60 | Mutism (HP:0002300) | 2.37129482 |
| 61 | Impaired vibratory sensation (HP:0002495) | 2.34719862 |
| 62 | Fetal akinesia sequence (HP:0001989) | 2.33319743 |
| 63 | Focal dystonia (HP:0004373) | 2.32471326 |
| 64 | Diplopia (HP:0000651) | 2.29469382 |
| 65 | Abnormality of binocular vision (HP:0011514) | 2.29469382 |
| 66 | CNS hypomyelination (HP:0003429) | 2.28599819 |
| 67 | Insomnia (HP:0100785) | 2.27550933 |
| 68 | Epileptiform EEG discharges (HP:0011182) | 2.25768902 |
| 69 | Diminished motivation (HP:0000745) | 2.23285358 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17513187 |
| 71 | Megalencephaly (HP:0001355) | 2.17155935 |
| 72 | Polyphagia (HP:0002591) | 2.13209268 |
| 73 | Pheochromocytoma (HP:0002666) | 2.10906943 |
| 74 | Incomplete penetrance (HP:0003829) | 2.08247572 |
| 75 | Increased circulating renin level (HP:0000848) | 2.08162710 |
| 76 | Hypsarrhythmia (HP:0002521) | 2.06767794 |
| 77 | Spinal canal stenosis (HP:0003416) | 2.04125277 |
| 78 | Abnormal EKG (HP:0003115) | 2.01752463 |
| 79 | Lower limb muscle weakness (HP:0007340) | 2.01689199 |
| 80 | Insidious onset (HP:0003587) | 2.00142967 |
| 81 | Termporal pattern (HP:0011008) | 2.00142967 |
| 82 | Rapidly progressive (HP:0003678) | 1.99151237 |
| 83 | Craniofacial dystonia (HP:0012179) | 1.98828272 |
| 84 | Absent speech (HP:0001344) | 1.97463910 |
| 85 | Hyperventilation (HP:0002883) | 1.96439634 |
| 86 | Abnormality of saccadic eye movements (HP:0000570) | 1.95514342 |
| 87 | Gait ataxia (HP:0002066) | 1.95133285 |
| 88 | Agitation (HP:0000713) | 1.94764255 |
| 89 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.92934884 |
| 90 | Obstructive sleep apnea (HP:0002870) | 1.92500713 |
| 91 | Ulnar claw (HP:0001178) | 1.90997152 |
| 92 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.90023774 |
| 93 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.90023774 |
| 94 | Drooling (HP:0002307) | 1.88591269 |
| 95 | Excessive salivation (HP:0003781) | 1.88591269 |
| 96 | Lower limb asymmetry (HP:0100559) | 1.88481264 |
| 97 | Clonus (HP:0002169) | 1.88126892 |
| 98 | Memory impairment (HP:0002354) | 1.87014012 |
| 99 | Dementia (HP:0000726) | 1.86435664 |
| 100 | Progressive inability to walk (HP:0002505) | 1.85828829 |
| 101 | Heart block (HP:0012722) | 1.85378565 |
| 102 | Split foot (HP:0001839) | 1.83055185 |
| 103 | Resting tremor (HP:0002322) | 1.81808793 |
| 104 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.81472869 |
| 105 | Aplasia of the phalanges of the hand (HP:0009802) | 1.81472869 |
| 106 | Aplasia involving bones of the extremities (HP:0009825) | 1.81472869 |
| 107 | Abnormality of the periventricular white matter (HP:0002518) | 1.81282083 |
| 108 | Hypercortisolism (HP:0001578) | 1.76107348 |
| 109 | Neuronal loss in central nervous system (HP:0002529) | 1.76097538 |
| 110 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.75957736 |
| 111 | Unsteady gait (HP:0002317) | 1.74596027 |
| 112 | Abnormality of the corticospinal tract (HP:0002492) | 1.73303879 |
| 113 | Prolonged QT interval (HP:0001657) | 1.72681899 |
| 114 | Central scotoma (HP:0000603) | 1.72252383 |
| 115 | Neuroendocrine neoplasm (HP:0100634) | 1.71000823 |
| 116 | Limb ataxia (HP:0002070) | 1.70145621 |
| 117 | Generalized myoclonic seizures (HP:0002123) | 1.69377241 |
| 118 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.68892111 |
| 119 | Failure to thrive in infancy (HP:0001531) | 1.67698353 |
| 120 | Postural tremor (HP:0002174) | 1.67607360 |
| 121 | Tetraplegia (HP:0002445) | 1.65076959 |
| 122 | Rigidity (HP:0002063) | 1.65045063 |
| 123 | Amyotrophic lateral sclerosis (HP:0007354) | 1.64981285 |
| 124 | Delusions (HP:0000746) | 1.64443483 |
| 125 | Hammertoe (HP:0001765) | 1.61845447 |
| 126 | Lower limb amyotrophy (HP:0007210) | 1.61666861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.31211760 |
| 2 | EPHA4 | 4.20004735 |
| 3 | MAP3K9 | 3.74708833 |
| 4 | DAPK2 | 3.09546214 |
| 5 | MINK1 | 2.89528028 |
| 6 | MAP3K4 | 2.88876741 |
| 7 | PRKD3 | 2.82679259 |
| 8 | PAK6 | 2.67454678 |
| 9 | CAMKK1 | 2.41100236 |
| 10 | MAP2K7 | 2.35565024 |
| 11 | KSR2 | 2.25806487 |
| 12 | MARK1 | 2.13979158 |
| 13 | MAP2K4 | 2.02326719 |
| 14 | NTRK1 | 1.96167810 |
| 15 | STK38 | 1.85259988 |
| 16 | DAPK1 | 1.80611097 |
| 17 | MAP3K12 | 1.74738029 |
| 18 | NTRK2 | 1.73480847 |
| 19 | PRPF4B | 1.61149158 |
| 20 | RIPK4 | 1.60809923 |
| 21 | PINK1 | 1.57585432 |
| 22 | CDK5 | 1.53078139 |
| 23 | SIK2 | 1.41268626 |
| 24 | GRK5 | 1.41107079 |
| 25 | UHMK1 | 1.33575350 |
| 26 | KSR1 | 1.32941159 |
| 27 | TYRO3 | 1.31235947 |
| 28 | CDK19 | 1.30388558 |
| 29 | CAMKK2 | 1.28738300 |
| 30 | MAP3K2 | 1.28012916 |
| 31 | PLK2 | 1.26925871 |
| 32 | PRKCG | 1.24047013 |
| 33 | MAPK13 | 1.22483367 |
| 34 | TNIK | 1.18077506 |
| 35 | TAOK1 | 1.11938137 |
| 36 | SGK223 | 1.10451866 |
| 37 | SGK494 | 1.10451866 |
| 38 | LATS2 | 1.06009899 |
| 39 | CAMK1 | 1.05238712 |
| 40 | ALK | 1.01876633 |
| 41 | RET | 0.97974291 |
| 42 | WNK1 | 0.97703449 |
| 43 | STK11 | 0.97386417 |
| 44 | RIPK1 | 0.96909053 |
| 45 | PRKCH | 0.96377338 |
| 46 | SGK2 | 0.95368229 |
| 47 | NEK1 | 0.94186448 |
| 48 | MAP3K11 | 0.94066091 |
| 49 | PHKG2 | 0.91936077 |
| 50 | PHKG1 | 0.91936077 |
| 51 | LMTK2 | 0.91647002 |
| 52 | CDK18 | 0.90724252 |
| 53 | SGK3 | 0.90585253 |
| 54 | CDK15 | 0.90356837 |
| 55 | MAP3K13 | 0.89657760 |
| 56 | CASK | 0.87206354 |
| 57 | ARAF | 0.85251679 |
| 58 | MAPK12 | 0.83325691 |
| 59 | CDK14 | 0.82346714 |
| 60 | FES | 0.80399244 |
| 61 | MARK2 | 0.80133537 |
| 62 | PKN1 | 0.79096025 |
| 63 | CDK11A | 0.78757710 |
| 64 | CAMK2A | 0.78292371 |
| 65 | CDC42BPA | 0.75634664 |
| 66 | PDK1 | 0.74756509 |
| 67 | TNK2 | 0.73906153 |
| 68 | BRSK1 | 0.73255567 |
| 69 | MAP3K6 | 0.71811245 |
| 70 | SGK1 | 0.71718057 |
| 71 | LIMK1 | 0.70739078 |
| 72 | DYRK1A | 0.68842614 |
| 73 | NEK6 | 0.67674185 |
| 74 | BMPR2 | 0.66464077 |
| 75 | MAP3K1 | 0.65722077 |
| 76 | CAMK4 | 0.65527719 |
| 77 | AKT3 | 0.65363464 |
| 78 | PDPK1 | 0.63525708 |
| 79 | RAF1 | 0.56704420 |
| 80 | PNCK | 0.56647860 |
| 81 | PAK3 | 0.56613447 |
| 82 | BRAF | 0.53848860 |
| 83 | PTK2B | 0.53793866 |
| 84 | CAMK2B | 0.53733248 |
| 85 | SIK3 | 0.53461521 |
| 86 | RPS6KA3 | 0.53367083 |
| 87 | DAPK3 | 0.52907887 |
| 88 | OXSR1 | 0.49736879 |
| 89 | PRKG2 | 0.49682129 |
| 90 | MAPK10 | 0.48108738 |
| 91 | FGFR2 | 0.48098182 |
| 92 | CCNB1 | 0.46813664 |
| 93 | SCYL2 | 0.46608404 |
| 94 | PRKCZ | 0.45163919 |
| 95 | CAMK2G | 0.44609047 |
| 96 | PRKCA | 0.39793210 |
| 97 | BMX | 0.39575707 |
| 98 | DDR2 | 0.38263936 |
| 99 | ROCK2 | 0.38245465 |
| 100 | MAP3K7 | 0.37073900 |
| 101 | MAP2K6 | 0.36724789 |
| 102 | PRKCE | 0.36102657 |
| 103 | CSNK1G2 | 0.35619446 |
| 104 | MAP2K1 | 0.35339347 |
| 105 | CAMK2D | 0.35303726 |
| 106 | FYN | 0.32304524 |
| 107 | ROCK1 | 0.30971564 |
| 108 | PRKD2 | 0.30778819 |
| 109 | TESK1 | 0.29937876 |
| 110 | DMPK | 0.29581954 |
| 111 | ERBB2 | 0.29410781 |
| 112 | MAPK8 | 0.29129118 |
| 113 | PRKCB | 0.27800241 |
| 114 | MAPK4 | 0.25870936 |
| 115 | PRKACA | 0.25848799 |
| 116 | PRKG1 | 0.24871429 |
| 117 | MAPKAPK5 | 0.24001903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.51437118 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.36823233 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.87994768 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.71474986 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.62510595 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.60632595 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.55588614 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.53988615 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.42859637 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.32348946 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.31852823 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.23808162 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.14625409 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.04903734 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.98200085 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.93884647 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.91632992 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76680121 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.75595844 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.71993386 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66982244 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.62641918 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55637398 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.53869873 |
| 25 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.52172946 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.44120935 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43981342 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40237540 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.40213431 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.37939653 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.36447310 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.34270042 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30816137 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.28616144 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.28046822 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27116044 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.19038896 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15965252 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09800796 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07624295 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06997333 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06475140 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 1.04222514 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 1.00808755 |
| 45 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97724092 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94200203 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92052263 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91830732 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.89511633 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88183722 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 0.87636868 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86779378 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86111191 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81200600 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80195435 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78306552 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76717681 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76130389 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75130826 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74598227 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72072068 |
| 62 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71573495 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70611181 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69450038 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67365512 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67059476 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65505045 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63632194 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62401542 |
| 70 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60014077 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59978084 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59439837 |
| 73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57666368 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56284223 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56080059 |
| 76 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55799728 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.55030388 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51414874 |
| 79 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50135663 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49930009 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48660044 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48440107 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.48146649 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45834897 |
| 85 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45209086 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45084030 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44253551 |
| 88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43337269 |
| 89 | Alcoholism_Homo sapiens_hsa05034 | 0.43217931 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42500663 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41608443 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41464741 |
| 93 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39569119 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39157191 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36532902 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.35745847 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35223128 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33289423 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33090233 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.32476473 |
| 101 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32160459 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32159001 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32113180 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31267374 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29409111 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29217125 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28603033 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27978730 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19012030 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17145351 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.16966279 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.16554172 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14694964 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13897165 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12762100 |

